| [1] |
|
| [2] |
Rueda ZV, Aguilar Y, Maya MA, et al. Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents[J]. BMC Pediatr, 2022, 22(1):169. doi: 10.1186/s12887-022-03235-z.
pmid: 35361166
|
| [3] |
|
| [4] |
|
| [5] |
Kirolos N, Mtaweh H, Datta RR, et al. Risk factors for severe disease among children hospitalized with respiratory syncytial virus[J]. JAMA Netw Open, 2025, 8(4):e254666. doi: 10.1001/jamanetworkopen.2025.4666.
|
| [6] |
|
| [7] |
Marangu-Boore D, Mwaniki P, Isaaka L, et al. Characteristics of children readmitted with severe pneumonia in Kenyan hospitals[J]. BMC Public Health, 2024, 24(1):1324. doi: 10.1186/s12889-024-18651-2.
pmid: 38755590
|
| [8] |
Xu Y, Yang C, Sun P, et al. Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: A 6-year study in southern China[J]. Emerg Microbes Infect, 2024, 13(1):2353298. doi: 10.1080/22221751.2024.2353298.
|
| [9] |
Liu J, Bao B, Zhang T, et al. Comparative analysis of the clinical characteristics of severe Mycoplasma pneumoniae pneumonia and severe bacterial pneumonia in children[J]. BMC Pediatr, 2025, 25(1):439. doi: 10.1186/s12887-025-05804-4.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
Xu W, Zhang X, Guan Y, et al. Clinical and CT characteristics of human metapneumovirus-associated severe pneumonia in children in Beijing[J]. Ital J Pediatr, 2025, 51(1):136. doi: 10.1186/s13052-025-01973-1.
pmid: 40346698
|
| [16] |
Nasrin S, Tariqujjaman M, Sultana M, et al. Factors associated with community acquired severe pneumonia among under five children in Dhaka, Bangladesh: A case control analysis[J]. PLoS One, 2022, 17(3):e0265871. doi: 10.1371/journal.pone.0265871.
|
| [17] |
|
| [18] |
Liang Y, Wu J, Chen G, et al. Risk factor analysis and prediction model construction for severe adenovirus pneumonia in children[J]. Ital J Pediatr, 2024, 50(1):210. doi: 10.1186/s13052-024-01771-1.
pmid: 39385312
|
| [19] |
Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and disease severity in children with community-acquired pneumonia[J]. Pediatrics, 2020, 145(6):e20193728. doi: 10.1542/peds.2019-3728.
|
| [20] |
Tran XD, Hoang VT, Goumballa N, et al. Viral and bacterial microorganisms in Vietnamese children with severe and non-severe pneumonia[J]. Sci Rep, 2024, 14(1):120. doi: 10.1038/s41598-023-50657-5.
|
| [21] |
Su DQ, Huang HL, Zhuo ZQ. Pathogen distribution and bacterial resistance in children with severe pneumonia: A single-center retrospective study[J]. Medicine (Baltimore), 2021, 100(35):e27128. doi: 10.1097/MD.0000000000027128.
|
| [22] |
Li F, Zhang Y, Shi P, et al. Mycoplasma pneumoniae and adenovirus coinfection cause pediatric severe community-acquired pneumonia[J]. Microbiol Spectr, 2022, 10(2):e0002622. doi: 10.1128/spectrum.00026-22.
|
| [23] |
Yu A, Ran L, Sun X, et al. Significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia[J]. BMC Pulm Med, 2024, 24(1):585.doi: 10.1186/s12890-024-03380-4.
|
| [24] |
Dubot-Pérès A, Lee SJ, Dance DAB, et al. Pneumococcal density and respiratory co-detection in severe pediatric pneumonia in Laos[J]. Sci Rep, 2025, 15(1):17708. doi: 10.1038/s41598-025-01659-y.
|
| [25] |
Zhang J, Zhuo Z, Xu Y, et al. Pneumonia in children during the 2019 outbreak in xiamen, China[J]. Pediatr Infect Dis J, 2023, 42(2):87-93. doi: 10.1097/INF.0000000000003749.
pmid: 36638390
|
| [26] |
Cao Y, Zhao L, Miao H. Risk factors for progression to severe pneumonia in children visiting the emergency department with pneumonia[J]. Chin J Crit Care Med, 2023, 35(5):528-532. doi: 10.3760/cma.j.cn121430-20220315-00248.
|
| [27] |
Yang S, Lu S, Guo Y, et al. A comparative study of general and severe Mycoplasma pneumoniae pneumonia in children[J]. BMC Infect Dis, 2024, 24(1):449. doi: 10.1186/s12879-024-09340-x.
|
| [28] |
冯妍, 陈美元, 吴建刚, 等. 重症肺炎患儿预后的影响因素及可溶性髓样细胞触发受体-1和高迁移率族蛋白B1对其预测价值[J]. 中华医院感染学杂志, 2023, 33(20):3146-3150. doi: 10.11816/cn.ni.2023-230358.
|
| [29] |
Kim KJ, Kim DH. The frequency and seasonal distribution of viral infection in patients with community-acquired pneumonia and its impact on the prognosis[J]. Acute Crit Care, 2022, 37(4):550-560. doi: 10.4266/acc.2022.00682.
|
| [30] |
Rifai M, Bergounioux J, Sleiman N, et al. Infectious acute respiratory failure in patients under 5 years of age: A retrospective cohort study[J]. BMJ Paediatr Open, 2024, 8(1):e002614. doi: 10.1136/bmjpo-2024-002614.
|
| [31] |
Choi YJ, Park JY, Lee HS, et al. Variable effects of underlying diseases on the prognosis of patients with COVID-19[J]. PLoS One, 2021, 16(7):e0254258. doi: 10.1371/journal.pone.0254258.
|
| [32] |
Luo Y, Wu R, Wu W, et al. Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children[J]. BMC Pediatr, 2025, 25(1):449. doi: 10.1186/s12887-025-05819-x.
pmid: 40462041
|